Synthesis of Heterocycles in Contemporary Medicinal Chemistry -

Synthesis of Heterocycles in Contemporary Medicinal Chemistry

Zdenko Časar (Herausgeber)

Buch | Softcover
IX, 273 Seiten
2018 | 1. Softcover reprint of the original 1st ed. 2016
Springer International Publishing (Verlag)
978-3-319-81995-2 (ISBN)
320,99 inkl. MwSt
The series Topics in Heterocyclic Chemistry presents critical reviews on present and future trends in the research of heterocyclic compounds. Overall the scope is to cover topics dealing with all areas within heterocyclic chemistry, both experimental and theoretical, of interest to the general heterocyclic chemistry community. The series consists of topic related volumes edited by renowned editors with contributions of experts in the field. All chapters from Topics in Heterocyclic Chemistry are published Online First with an individual DOI. In references, Topics in Heterocyclic Chemistry is abbreviated as Top Heterocycl Chem and cited as a journal.

Development of a Manufacturing Process for the Formation of a Nucleoside Drug Candidate.- Development of Efficient Routes to Access C-Glycosides as SGLT-2 Inhibitors for the Treatment of Type 2 Diabetes.- Synthetic Routes to Sofosbuvir.- Synthetic Challenges in the Assembly of Macrocyclic HCV NS3/NS4A Protease Inhibitors: The Case of BILN 2061 and Its Analogs.- Recent Progress in the Synthesis of Super-Statins.- Development of Synthetic Routes to Dolutegravir.- Story of Eribulin Mesylate: Development of the Longest Drug Synthesis.

Erscheinungsdatum
Reihe/Serie Topics in Heterocyclic Chemistry
Zusatzinfo IX, 273 p. 42 illus., 31 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 4336 g
Themenwelt Medizin / Pharmazie Pharmazie
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Biochemie
Naturwissenschaften Chemie Analytische Chemie
Naturwissenschaften Chemie Organische Chemie
Naturwissenschaften Chemie Physikalische Chemie
Schlagworte C-glycosides as SGLT-2 Inhibitors • Dolutegravir • drug synthesis • Eribulin Mesylate • HCV NS3 Protease Inhibitors • Heterocycles in Medicinal Chemistry • Nucleoside Drug Candidate Formation • Sofosbuvir • Synthesis of Super-Statins • Treatment of Type 2 Diabetes
ISBN-10 3-319-81995-X / 331981995X
ISBN-13 978-3-319-81995-2 / 9783319819952
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Reinhard Matissek; Andreas Hahn

Buch | Hardcover (2024)
Springer Spektrum (Verlag)
79,99

von Birgit Piechulla; Hans Walter Heldt

Buch | Hardcover (2023)
Springer Spektrum (Verlag)
79,99